The Growing Administrative Complexity of Axial SpA Practices
Ankylosing spondylitis (AS) and non-radiographic axial spondyloarthritis (nr-axSpA) represent a growing segment of rheumatology practice — and one of the most biologic-intensive. The Assessment of SpondyloArthritis International Society (ASAS) estimates that 0.2 to 0.5 percent of the general population has axial spondyloarthritis, with the majority of moderate-to-severe patients requiring biologic therapy.
TNF inhibitors (adalimumab, etanercept, certolizumab, golimumab) and IL-17 inhibitors (secukinumab, ixekizumab) dominate the treatment landscape, each requiring prior authorization workflows that are increasingly granular. Payers routinely require documentation of BASDAI scores, NSAID failure records, and baseline MRI sacroiliac joint imaging before approving biologics — creating a documentation-intensive access bottleneck.
Virtual assistants trained in axial SpA workflows are helping practices manage this complexity efficiently.
BASDAI Documentation: Longitudinal Tracking for Clinical and Payer Use
The Bath Ankylosing Spondylitis Disease Activity Index (BASDAI) is a six-item patient-reported outcome measure capturing fatigue, spinal pain, peripheral joint pain and swelling, localized tenderness, and morning stiffness. A BASDAI score of ≥4 is generally used as the threshold for biologic initiation or continuation, making longitudinal documentation of scores critical for both clinical management and insurance coverage.
A spondyloarthropathy VA can:
- Distribute BASDAI questionnaires via patient portal or pre-visit intake form before each encounter
- Log scores longitudinally in an EHR flowsheet or spreadsheet tracker, calculating moving averages and flagging scores above or below the 4.0 threshold
- Package BASDAI trend documentation for prior authorization submissions and step therapy appeals — demonstrating inadequate disease control despite NSAID therapy and supporting biologic necessity
- Track BASDAI response to biologic therapy as part of continuation authorization documentation, where a 50 percent improvement or 2-point reduction is the standard payer threshold
MRI Sacroiliac Joint Surveillance Scheduling
Baseline MRI of the sacroiliac joints is required for both diagnosis and biologic authorization in axial SpA. Surveillance imaging — typically every 2 to 3 years in treated patients, or more frequently with clinical concern — must be proactively scheduled to maintain continuous biologic coverage.
A VA can maintain an MRI surveillance calendar for the entire AS/axSpA patient panel: tracking baseline imaging dates, calculating surveillance due dates, scheduling MRI appointments with radiology, coordinating insurance pre-authorization for the imaging, and ensuring radiologist reports are received and filed in the EHR ahead of authorization renewal windows. Missing a surveillance MRI 30 days before a biologic renewal is due can cause a coverage gap — proactive tracking prevents this.
TNF Inhibitor Prior Authorization: Managing the Full Lifecycle
TNF inhibitor prior authorization for axial SpA patients involves layered documentation requirements that vary by payer: NSAID trial records (typically 2 to 4 weeks at adequate doses), BASDAI or ASDAS disease activity scores at initiation, baseline labs (TB screening, hepatitis B/C serology, CBC), and for Medicare patients, compliance with the ASAS response criteria at 12 weeks for continuation.
A VA can manage the full TNF inhibitor PA lifecycle: initial submission with clinical summary package, real-time denial tracking, peer-to-peer review scheduling, and 6- and 12-month renewal initiation. For practices managing 100+ axial SpA patients on biologics, this represents a substantial ongoing workload that consumes significant staff time when not systematically delegated.
Physical Therapy Referral and Exercise Program Coordination
Exercise and physical therapy are cornerstone non-pharmacologic interventions for axial SpA, recommended by ASAS and ACR guidelines. Coordinating physical therapy referrals — including finding PT providers with AS experience, obtaining insurance authorization for sessions, and tracking patient attendance and progress reports — is often deprioritized due to administrative load.
A VA can own the PT referral pipeline: identifying PT providers in-network with AS-specific experience, processing referral documentation, tracking authorization for PT sessions, and following up with patients to ensure exercise program adherence. This coordination supports the multidisciplinary management model that outcomes data consistently shows improves axial SpA function.
Stealth Agents provides ankylosing spondylitis and spondyloarthropathy practices with virtual assistants trained in BASDAI tracking, TNF inhibitor prior authorization, imaging surveillance workflows, and physical therapy coordination.
Sources
- Assessment of SpondyloArthritis International Society (ASAS). ASAS Recommendations for the Management of Axial SpA. 2022. https://www.asas-group.org
- American College of Rheumatology. 2019 ACR/SAA/SPARTAN Guidelines for Ankylosing Spondylitis and nr-axSpA. https://www.rheumatology.org
- Sieper J, et al. The BASDAI: A Valid Score of Disease Activity. British Journal of Rheumatology. 1994.
- Braun J, et al. MRI Sacroiliac Joints in Axial Spondyloarthritis. Arthritis & Rheumatology. 2021.
- Medical Group Management Association (MGMA). Prior Authorization Time Burden in Specialty Practices. 2023. https://www.mgma.com